Caryn Lerman - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Nicotine, Pharmacology, Public Health
Website:
http://www.med.upenn.edu/apps/faculty/index.php/g275/p11960

136 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Falcone M, Luo C, Chen Y, Birtwell D, Cheatle M, Duan R, Gabriel PE, He L, Ko EM, Lenz HJ, Mirkovic N, Mowery DL, Ochroch EAA, Paulson ECC, Schriver E, ... ... Lerman C, et al. Risk of persistent opioid use following major surgery in matched samples of patients with and without cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32859580 DOI: 10.1158/1055-9965.EPI-20-0628  0.48
2020 Ashare RL, Wileyto EP, Logue-Chamberlain E, Gross R, Tyndale RF, Lerman C, Hawk LW, Cinciripini P, George TP, Lubitz SF, Schnoll R. Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 32686950 DOI: 10.1037/adb0000619  0.52
2020 Schnoll R, Paul Wileyto E, Gross R, Hitsman B, Hawk LW, Cinciripini P, George TP, Benowitz NL, Fen Lubitz S, Ashare R, Tyndale RF, Lerman C. Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial. Drug and Alcohol Dependence. 210: 107967. PMID 32224420 DOI: 10.1016/j.drugalcdep.2020.107967  0.52
2020 Buchwald J, Chenoweth MJ, Palviainen T, Zhu G, Benner C, Gordon S, Korhonen T, Ripatti S, Madden PAF, Lehtimäki T, Raitakari OT, Salomaa V, Rose RJ, George TP, Lerman C, et al. Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent. Molecular Psychiatry. PMID 32157176 DOI: 10.1038/s41380-020-0702-z  0.52
2020 Siegel SD, Lerman C, Flitter A, Schnoll RA. The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. Cancer Prevention Research (Philadelphia, Pa.). 13: 261-272. PMID 32132120 DOI: 10.1158/1940-6207.CAPR-19-0259  0.48
2019 Frank DW, Cinciripini PM, Deweese MM, Karam-Hage M, Kypriotakis G, Lerman C, Robinson JD, Tyndale RF, Vidrine DJ, Versace F. Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31724052 DOI: 10.1093/ntr/ntz211  0.52
2019 Peng AR, Swardfager W, Benowitz NL, Ahluwalia JS, Lerman C, Nollen NL, Tyndale RF. Impact of Early Nausea on Varenicline Adherence and Smoking Cessation. Addiction (Abingdon, England). PMID 31502736 DOI: 10.1111/add.14810  0.52
2019 Allenby C, Falcone M, Ashare RL, Cao W, Bernardo L, Wileyto EP, Pruessner J, Loughead J, Lerman C. Brain Marker Links Stress and Nicotine Abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31120113 DOI: 10.1093/ntr/ntz077  0.4
2019 Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). 33: 1083-1088. PMID 30946162 DOI: 10.1097/QAD.0000000000002127  0.52
2019 El-Boraie A, Taghavi T, Chenoweth MJ, Fukunaga K, Mushiroda T, Kubo M, Lerman C, Nollen NL, Benowitz NL, Tyndale RF. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. Addiction Biology. PMID 30815984 DOI: 10.1111/adb.12741  0.52
2019 Allenby C, Falcone M, Wileyto EP, Cao W, Bernardo L, Ashare RL, Janes A, Loughead J, Lerman C. Neural cue reactivity during acute abstinence predicts short-term smoking relapse. Addiction Biology. PMID 30806013 DOI: 10.1111/adb.12733  0.4
2019 Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). PMID 30649060 DOI: 10.1097/QAD.0000000000002127  0.52
2019 Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 30614717 DOI: 10.1037/adb0000434  0.52
2019 Falcone M, Bernardo L, Wileyto EP, Allenby C, Burke AM, Hamilton R, Cristancho M, Ashare RL, Loughead J, Lerman C. Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial. Drug and Alcohol Dependence. 194: 244-251. PMID 30497056 DOI: 10.1016/j.drugalcdep.2018.10.016  0.4
2018 Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial. Jama Network Open. 1. PMID 30627706 DOI: 10.1001/jamanetworkopen.2018.1346  0.52
2018 To C, Falcone M, Loughead J, Logue-Chamberlain E, Hamilton R, Kable J, Lerman C, Ashare RL. Got chocolate? Bilateral prefrontal cortex stimulation augments chocolate consumption. Appetite. 131: 28-35. PMID 30171915 DOI: 10.1016/j.appet.2018.08.032  0.4
2018 Peng AR, Schnoll R, Hawk LW, Cinciripini P, George TP, Lerman C, Tyndale RF. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes. Drug and Alcohol Dependence. 190: 72-81. PMID 29986268 DOI: 10.1016/j.drugalcdep.2018.04.035  0.52
2018 Allenby C, Falcone M, Bernardo L, Wileyto EP, Rostain A, Ramsay JR, Lerman C, Loughead J. Transcranial direct current brain stimulation decreases impulsivity in ADHD. Brain Stimulation. PMID 29885858 DOI: 10.1016/j.brs.2018.04.016  0.4
2018 Taghavi T, Novalen M, Lerman C, George TP, Tyndale RF. A comparison of direct and indirect analytical approaches to measuring total nicotine equivalents in urine. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29853480 DOI: 10.1158/1055-9965.EPI-18-0018  0.52
2018 Tanner JA, Zhu AZ, Claw KG, Prasad B, Korchina V, Hu J, Doddapaneni H, Muzny DM, Schuetz EG, Lerman C, Thummel KE, Scherer SE, Tyndale RF. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. Pharmacogenetics and Genomics. 28: 7-16. PMID 29232328 DOI: 10.1097/FPC.0000000000000317  0.52
2017 Peng AR, Le Foll B, Morales M, Lerman C, Schnoll R, Tyndale RF. Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017). Addictive Behaviors. 79: 14-16. PMID 29232593 DOI: 10.1016/j.addbeh.2017.11.032  0.52
2017 Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF, et al. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Addiction (Abingdon, England). PMID 28921760 DOI: 10.1111/add.14032  0.52
2017 Peng AR, Morales M, Wileyto EP, Hawk LW, Cinciripini P, George TP, Benowitz NL, Nollen NL, Lerman C, Tyndale RF, Schnoll R. Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addictive Behaviors. 75: 122-129. PMID 28728040 DOI: 10.1016/j.addbeh.2017.07.006  0.52
2017 Ashare RL, Lerman C, Tyndale RF, Hawk LW, George TP, Cinciripini P, Schnoll RA. Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? Journal of Smoking Cessation. 12: 63-70. PMID 28553407 DOI: 10.1017/jsc.2016.11  0.52
2016 Loughead J, Falcone M, Wileyto EP, Albelda B, Audrain-McGovern J, Cao W, Kurtz MM, Gur RC, Lerman C. Can brain games help smokers quit?: Results of a randomized clinical trial. Drug and Alcohol Dependence. 168: 112-118. PMID 27635998 DOI: 10.1016/j.drugalcdep.2016.08.621  0.4
2016 Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW, Lerman C, Tyndale RF, George TP. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 27187893 DOI: 10.1111/ajad.12382  0.52
2016 Ross KC, Gubner NR, Tyndale RF, Hawk LW, Lerman C, George TP, Cinciripini P, Schnoll RA, Benowitz NL. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacology, Biochemistry, and Behavior. PMID 27180107 DOI: 10.1016/j.pbb.2016.05.002  0.52
2016 Ashare RL, Lerman C, Cao W, Falcone M, Bernardo L, Ruparel K, Hopson R, Gur R, Pruessner JC, Loughead J. Nicotine withdrawal alters neural responses to psychosocial stress. Psychopharmacology. PMID 27087432 DOI: 10.1007/s00213-016-4299-5  0.4
2015 Falcone M, Cao W, Bernardo L, Tyndale RF, Loughead J, Lerman C. Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate. Biological Psychiatry. PMID 26805583 DOI: 10.1016/j.biopsych.2015.11.015  0.52
2015 Webb A, Papp AC, Curtis A, Newman LC, Pietrzak M, Seweryn M, Handelman SK, Rempala GA, Wang D, Graziosa E, Tyndale RF, Lerman C, Kelsoe JR, Mash DC, Sadee W. RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles. Bmc Genomics. 16: 990. PMID 26597164 DOI: 10.1186/s12864-015-2207-8  0.52
2015 Falcone M, Bernardo L, Ashare RL, Hamilton R, Faseyitan O, McKee SA, Loughead J, Lerman C. Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking. Brain Stimulation. PMID 26572280 DOI: 10.1016/j.brs.2015.10.004  0.4
2015 Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody AL, Hou C, Schmitz A, Lerman C. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1724-9. PMID 26272810 DOI: 10.2967/jnumed.115.155002  0.52
2015 Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, ... Lerman C, et al. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. Plos One. 10: e0126113. PMID 26132489 DOI: 10.1371/journal.pone.0126113  0.52
2015 Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW, George TP, Cinciripini PM, Lerman C, Tyndale RF. The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 26069034 DOI: 10.1093/ntr/ntv125  0.52
2015 Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanpää A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF. Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26014804 DOI: 10.1158/1055-9965.EPI-14-1381  0.52
2015 Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. Plos One. 10: e0128109. PMID 26010901 DOI: 10.1371/journal.pone.0128109  0.52
2015 Hamilton DA, Mahoney MC, Novalen M, Chenoweth MJ, Heitjan DF, Lerman C, Tyndale RF, Hawk LW. Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25732567 DOI: 10.1093/ntr/ntv031  0.52
2015 Lerman C, Schnoll RA, Hawk LW, Cinciripini P, George TP, Wileyto EP, Swan GE, Benowitz NL, Heitjan DF, Tyndale RF. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. The Lancet. Respiratory Medicine. 3: 131-8. PMID 25588294 DOI: 10.1016/S2213-2600(14)70294-2  0.52
2015 Loughead J, Wileyto EP, Ruparel K, Falcone M, Hopson R, Gur R, Lerman C. Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1311-20. PMID 25469682 DOI: 10.1038/npp.2014.318  0.4
2014 Chenoweth MJ, Novalen M, Hawk LW, Schnoll RA, George TP, Cinciripini PM, Lerman C, Tyndale RF. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1773-82. PMID 25012994 DOI: 10.1158/1055-9965.EPI-14-0427  0.52
2014 Leventhal AM, Lee W, Bergen AW, Swan GE, Tyndale RF, Lerman C, Conti DV. Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. Drug and Alcohol Dependence. 138: 109-17. PMID 24667010 DOI: 10.1016/j.drugalcdep.2014.02.016  0.52
2014 Lerman C, Gu H, Loughead J, Ruparel K, Yang Y, Stein EA. Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. Jama Psychiatry. 71: 523-30. PMID 24622915 DOI: 10.1001/jamapsychiatry.2013.4091  0.52
2014 Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Molecular Psychiatry. 19: 801-10. PMID 23999525 DOI: 10.1038/mp.2013.104  0.52
2014 Ashare RL, Falcone M, Lerman C. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology. 76: 581-91. PMID 23639437 DOI: 10.1016/j.neuropharm.2013.04.034  0.32
2014 Falcone M, Wileyto EP, Ruparel K, Gerraty RT, LaPrate L, Detre JA, Gur R, Loughead J, Lerman C. Age-related differences in working memory deficits during nicotine withdrawal. Addiction Biology. 19: 907-17. PMID 23496760 DOI: 10.1111/adb.12051  0.52
2013 Parvanta S, Gibson L, Forquer H, Shapiro-Luft D, Dean L, Freres D, Lerman C, Mallya G, Moldovan-Johnson M, Tan A, Cappella J, Hornik R. Applying Quantitative Approaches to the Formative Evaluation of Antismoking Campaign Messages. Social Marketing Quarterly. 19: 242-264. PMID 24817829 DOI: 10.1177/1524500413506004  0.52
2013 Ashare RL, Wileyto EP, Ruparel K, Goelz PM, Hopson RD, Valdez JN, Gur RC, Loughead J, Lerman C. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Drug and Alcohol Dependence. 133: 852-6. PMID 24095246 DOI: 10.1016/j.drugalcdep.2013.09.003  0.52
2013 David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction (Abingdon, England). 108: 2202-11. PMID 23941313 DOI: 10.1111/add.12325  0.52
2013 Ashare RL, Valdez JN, Ruparel K, Albelda B, Hopson RD, Keefe JR, Loughead J, Lerman C. Association of abstinence-induced alterations in working memory function and COMT genotype in smokers. Psychopharmacology. 230: 653-62. PMID 23828159 DOI: 10.1007/s00213-013-3197-3  0.52
2013 Falcone M, Smith RM, Chenoweth MJ, Bhattacharjee AK, Kelsoe JR, Tyndale RF, Lerman C. Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2327-37. PMID 23793356 DOI: 10.1038/npp.2013.152  0.52
2013 Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction (Abingdon, England). 108: 1962-8. PMID 23773319 DOI: 10.1111/add.12273  0.52
2013 Falcone M, Lerman C, Cappella JN, Sanborn P, Jepson C, Strasser AA. No untoward effects of smoking cues in anti-smoking public service announcements. Drug and Alcohol Dependence. 133: 279-82. PMID 23742844 DOI: 10.1016/j.drugalcdep.2013.05.006  0.52
2013 Perkins KA, Karelitz JL, Jao NC, Gur RC, Lerman C. Effects of bupropion on cognitive performance during initial tobacco abstinence. Drug and Alcohol Dependence. 133: 283-6. PMID 23726977 DOI: 10.1016/j.drugalcdep.2013.05.003  0.52
2013 Wang AL, Ruparel K, Loughead JW, Strasser AA, Blady SJ, Lynch KG, Romer D, Cappella JN, Lerman C, Langleben DD. Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7420-7. PMID 23616548 DOI: 10.1523/JNEUROSCI.3840-12.2013  0.52
2013 Zhu AZ, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 708-18. PMID 23371292 DOI: 10.1158/1055-9965.EPI-12-1234-T  0.52
2013 Bergen AW, Javitz HS, Krasnow R, Nishita D, Michel M, Conti DV, Liu J, Lee W, Edlund CK, Hall S, Kwok PY, Benowitz NL, Baker TB, Tyndale RF, Lerman C, et al. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenetics and Genomics. 23: 94-103. PMID 23249876 DOI: 10.1097/FPC.0b013e32835cdabd  0.52
2013 Bergen AW, Javitz HS, Su L, He Y, Conti DV, Benowitz NL, Tyndale RF, Lerman C, Swan GE. The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 1190-200. PMID 23212438 DOI: 10.1093/ntr/nts245  0.52
2013 Lee S, Cappella JN, Lerman C, Strasser AA. Effects of smoking cues and argument strength of antismoking advertisements on former smokers' self-efficacy, attitude, and intention to refrain from smoking. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 527-33. PMID 22949578 DOI: 10.1093/ntr/nts171  0.52
2013 Loughead J, Ray R, Wileyto EP, Ruparel K, O'Donnell GP, Senecal N, Siegel S, Gur RC, Lerman C. Brain activity and emotional processing in smokers treated with varenicline. Addiction Biology. 18: 732-8. PMID 21507156 DOI: 10.1111/j.1369-1600.2011.00324.x  0.52
2012 Featherstone RE, Phillips JM, Thieu T, Ehrlichman RS, Halene TB, Leiser SC, Christian E, Johnson E, Lerman C, Siegel SJ. Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials. Plos One. 7: e39775. PMID 22911690 DOI: 10.1371/journal.pone.0039775  0.52
2012 Kim HS, Bigman CA, Leader AE, Lerman C, Cappella JN. Narrative Health Communication and Behavior Change: The Influence of Exemplars in the News on Intention to Quit Smoking. The Journal of Communication. 62: 473-492. PMID 22736808 DOI: 10.1111/j.1460-2466.2012.01644.x  0.52
2012 Ashare RL, Ray R, Lerman C, Strasser AA. Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study. Drug and Alcohol Dependence. 126: 263-7. PMID 22595038 DOI: 10.1016/j.drugalcdep.2012.04.019  0.52
2012 Lee W, Ray R, Bergen AW, Swan GE, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers. Pharmacogenetics and Genomics. 22: 551-4. PMID 22495174 DOI: 10.1097/FPC.0b013e3283539062  0.52
2012 Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C. Smoking in response to negative mood in men versus women as a function of distress tolerance. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 14: 1418-25. PMID 22416115 DOI: 10.1093/ntr/nts075  0.52
2012 Falcone M, Gold AB, Wileyto EP, Ray R, Ruparel K, Newberg A, Dubroff J, Logan J, Zubieta JK, Blendy JA, Lerman C. μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology. 222: 701-8. PMID 22389047 DOI: 10.1007/s00213-012-2673-5  0.52
2012 Gold AB, Wileyto EP, Lori A, Conti D, Cubells JF, Lerman C. Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1683-8. PMID 22373943 DOI: 10.1038/npp.2012.13  0.4
2012 Javitz HS, Lerman C, Swan GE. Comparative dynamics of four smoking withdrawal symptom scales Addiction. 107: 1501-1511. PMID 22321019 DOI: 10.1111/j.1360-0443.2012.03838.x  0.52
2012 Cao YA, Featherstone RE, Gandal MJ, Liang Y, Jutzeler C, Saunders J, Tatard-Leitman V, Chen J, Weinberger DR, Lerman C, Siegel SJ. Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density. Behavioral Neuroscience. 126: 332-43. PMID 22309446 DOI: 10.1037/a0027047  0.52
2012 Schnoll RA, Wileyto EP, Lerman C. Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addictive Behaviors. 37: 565-8. PMID 22244706 DOI: 10.1016/j.addbeh.2011.12.009  0.48
2012 King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 641-50. PMID 22048466 DOI: 10.1038/npp.2011.232  0.52
2012 Lee W, Bergen AW, Swan GE, Li D, Liu J, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. Gender-stratified gene and gene-treatment interactions in smoking cessation. The Pharmacogenomics Journal. 12: 521-32. PMID 21808284 DOI: 10.1038/tpj.2011.30  0.52
2011 Zhao X, Strasser A, Cappella JN, Lerman C, Fishbein M. A Measure of Perceived Argument Strength: Reliability and Validity. Communication Methods and Measures. 5: 48-75. PMID 25568663 DOI: 10.1080/19312458.2010.547822  0.52
2011 Schnoll RA, Cappella J, Lerman C, Pinto A, Patterson F, Wileyto EP, Bigman C, Leone F. A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial. Health Communication. 26: 735-42. PMID 21667366 DOI: 10.1080/10410236.2011.566829  0.52
2011 Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proceedings of the National Academy of Sciences of the United States of America. 108: 9268-73. PMID 21576462 DOI: 10.1073/pnas.1018699108  0.52
2011 Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale RF, Lerman C, Ray R. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 498-503. PMID 21385908 DOI: 10.1093/ntr/ntr012  0.52
2011 Lee S, Cappella JN, Lerman C, Strasser AA. Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 282-90. PMID 21330273 DOI: 10.1093/ntr/ntq255  0.52
2011 Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, Tyndale RF, Lerman CE. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 234-8. PMID 21212060 DOI: 10.1158/1055-9965.EPI-10-0674  0.52
2010 Rudnick ND, Strasser AA, Phillips JM, Jepson C, Patterson F, Frey JM, Turetsky BI, Lerman C, Siegel SJ. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 589-97. PMID 20395358 DOI: 10.1093/ntr/ntq049  0.52
2010 Wei J, Ma JZ, Payne TJ, Cui W, Ray R, Mitra N, Lerman C, Li MD. Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers. Human Genetics. 127: 691-8. PMID 20383528 DOI: 10.1007/s00439-010-0818-3  0.52
2010 Lerman C, Jepson C, Wileyto EP, Patterson F, Schnoll R, Mroziewicz M, Benowitz N, Tyndale RF. Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clinical Pharmacology and Therapeutics. 87: 553-7. PMID 20336063 DOI: 10.1038/clpt.2010.3  0.52
2010 Perkins KA, Mercincavage M, Fonte CA, Lerman C. Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence Psychopharmacology. 210: 45-51. PMID 20306175 DOI: 10.1007/s00213-010-1816-9  0.52
2010 Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biological Psychiatry. 67: 715-21. PMID 20207347 DOI: 10.1016/j.biopsych.2010.01.016  0.52
2010 Leader AE, Lerman C, Cappella JN. Nicotine vaccines: will smokers take a shot at quitting? Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 390-7. PMID 20185516 DOI: 10.1093/ntr/ntq015  0.52
2010 Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1374-82. PMID 20147892 DOI: 10.1038/npp.2010.7  0.52
2010 Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, Asch DA, Lerman C. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Annals of Internal Medicine. 152: 144-51. PMID 20124230 DOI: 10.7326/0003-4819-152-3-201002020-00005  0.52
2010 Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C. Working memory deficits predict short-term smoking resumption following brief abstinence Drug and Alcohol Dependence. 106: 61-64. PMID 19733449 DOI: 10.1016/j.drugalcdep.2009.07.020  0.52
2009 Perkins KA, Lerman C, Mercincavage M, Fonte CA, Briski JL. Nicotinic acetylcholine receptor β2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch Cancer Epidemiology Biomarkers and Prevention. 18: 2608-2612. PMID 19755656 DOI: 10.1158/1055-9965.EPI-09-0166  0.52
2009 Stefanek ME, Andrykowski MA, Lerman C, Manne S, Glanz K. Behavioral oncology and the war on cancer: partnering with biomedicine. Cancer Research. 69: 7151-6. PMID 19706775 DOI: 10.1158/0008-5472.CAN-08-4005  0.52
2009 Baker TB, Cummings KM, Hatsukami DK, Johnson CA, Lerman C, Niaura R, O'Malley SS. Transdisciplinary Tobacco Use Research Centers: research achievements and future implications. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 1231-44. PMID 19633277 DOI: 10.1093/ntr/ntp112  0.52
2009 Ray R, Schnoll RA, Lerman C. Nicotine dependence: biology, behavior, and treatment. Annual Review of Medicine. 60: 247-60. PMID 19630572 DOI: 10.1146/annurev.med.60.041707.160511  0.52
2009 Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proceedings of the National Academy of Sciences of the United States of America. 106: 10847-52. PMID 19528658 DOI: 10.1073/pnas.0901800106  0.52
2009 Thomas PD, Mi H, Swan GE, Lerman C, Benowitz N, Tyndale RF, Bergen AW, Conti DV. A systems biology network model for genetic association studies of nicotine addiction and treatment. Pharmacogenetics and Genomics. 19: 538-51. PMID 19525886 DOI: 10.1097/FPC.0b013e32832e2ced  0.52
2009 Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D, Guo N, Mi H, Thomas PD, Lessov-Schlaggar CN, Krasnow R, He Y, Nishita D, Jiang R, McClure JB, ... ... Lerman C, et al. Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2252-64. PMID 19494806 DOI: 10.1038/npp.2009.52  0.52
2009 Langleben DD, Loughead JW, Ruparel K, Hakun JG, Busch-Winokur S, Holloway MB, Strasser AA, Cappella JN, Lerman C. Reduced prefrontal and temporal processing and recall of high "sensation value" ads. Neuroimage. 46: 219-25. PMID 19457412 DOI: 10.1016/j.neuroimage.2008.12.062  0.52
2009 Saccone SF, Bierut LJ, Chesler EJ, Kalivas PW, Lerman C, Saccone NL, Uhl GR, Li CY, Philip VM, Edenberg HJ, Sherry ST, Feolo M, Moyzis RK, Rutter JL. Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm. Plos One. 4: e5225. PMID 19381300 DOI: 10.1371/journal.pone.0005225  0.52
2009 Kang Y, Cappella JN, Strasser AA, Lerman C. The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 254-61. PMID 19251767 DOI: 10.1093/ntr/ntn033  0.52
2009 Strasser AA, Cappella JN, Jepson C, Fishbein M, Tang KZ, Han E, Lerman C. Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 293-302. PMID 19246628 DOI: 10.1093/ntr/ntn026  0.52
2009 Stepanov I, Carmella SG, Han S, Pinto A, Strasser AA, Lerman C, Hecht SS. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 99-105. PMID 19246447 DOI: 10.1093/ntr/ntn004  0.32
2009 Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, Freifelder R, Karp J, Lerman C, Divgi C. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent. Nuclear Medicine Communications. 30: 314-8. PMID 19242386 DOI: 10.1097/MNM.0b013e328329a0ec  0.52
2009 Ray R, Tyndale RF, Lerman C. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. Journal of Neurogenetics. 23: 252-61. PMID 19169923 DOI: 10.1080/01677060802572887  0.52
2009 Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacology, Biochemistry, and Behavior. 92: 6-11. PMID 19000709 DOI: 10.1016/j.pbb.2008.10.016  0.52
2009 Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C. Varenicline improves mood and cognition during smoking abstinence. Biological Psychiatry. 65: 144-9. PMID 18842256 DOI: 10.1016/j.biopsych.2008.08.028  0.52
2009 Perkins KA, Coddington SB, Karelitz JL, Jetton C, Scott JA, Wilson AS, Lerman C. Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. Drug and Alcohol Dependence. 99: 47-57. PMID 18775605 DOI: 10.1016/j.drugalcdep.2008.06.017  0.52
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prevention Research (Philadelphia, Pa.). 1: 393-5. PMID 19138984 DOI: 10.1158/1940-6207.CAPR-08-0176  0.52
2008 Penning TM, Lerman C. Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment. Cancer Prevention Research (Philadelphia, Pa.). 1: 80-3. PMID 19138939 DOI: 10.1158/1940-6207.CAPR-08-0047  0.52
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2903-5. PMID 18990728 DOI: 10.1158/1055-9965.EPI-08-0888  0.52
2008 Furberg H, Lichtenstein P, Pedersen NL, Thornton L, Bulik CM, Lerman C, Sullivan PF. The STAGE cohort: A prospective study of tobacco use among Swedish twins Nicotine and Tobacco Research. 10: 1727-1735. PMID 18988069 DOI: 10.1080/14622200802443551  0.52
2008 Raybuck JD, Portugal GS, Lerman C, Gould TJ. Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behavioral Neuroscience. 122: 1166-71. PMID 18823172 DOI: 10.1037/a0012601  0.52
2008 Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA, Bergen AW, Benowitz NL. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behavioural Pharmacology. 19: 641-9. PMID 18690118 DOI: 10.1097/FBP.0b013e32830c367c  0.52
2008 Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A, Jennings JR, Ferrell R, Bergen AW, Benowitz NL. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Behavioural Pharmacology. 19: 630-40. PMID 18690117 DOI: 10.1097/FBP.0b013e32830c3621  0.52
2008 Perkins KA, Lerman C, Coddington SB, Jetton C, Karelitz JL, Scott JA, Wilson AS. Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology. 200: 529-44. PMID 18604520 DOI: 10.1007/s00213-008-1231-7  0.52
2008 Ray R, Loughead J, Wang Z, Detre J, Yang E, Gur R, Lerman C. Neuroimaging, genetics and the treatment of nicotine addiction Behavioural Brain Research. 193: 159-169. PMID 18599130 DOI: 10.1016/j.bbr.2008.05.021  0.52
2008 Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD, Bergen AW, Swan GE, Tyndale RF, Benowitz NL, Lerman C. Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Human Molecular Genetics. 17: 2834-48. PMID 18593715 DOI: 10.1093/hmg/ddn181  0.52
2008 Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Fiore MC, Baker TB. Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1009-20. PMID 18584464 DOI: 10.1080/14622200802097563  0.52
2008 Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S, Perkins KA, Dackis C, Heitjan DF, Berrettini W, Lerman C. A placebo-controlled trial of modafinil for nicotine dependence. Drug and Alcohol Dependence. 98: 86-93. PMID 18541389 DOI: 10.1016/j.drugalcdep.2008.04.008  0.52
2008 Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Archives of General Psychiatry. 65: 683-93. PMID 18519826 DOI: 10.1001/archpsyc.65.6.683  0.52
2008 Wang Z, Ray R, Faith M, Tang K, Wileyto EP, Detre JA, Lerman C. Nicotine abstinence-induced cerebral blood flow changes by genotype. Neuroscience Letters. 438: 275-80. PMID 18499348 DOI: 10.1016/j.neulet.2008.04.084  0.52
2008 Patterson F, Kerrin K, Wileyto EP, Lerman C. Increase in anger symptoms after smoking cessation predicts relapse. Drug and Alcohol Dependence. 95: 173-6. PMID 18328642 DOI: 10.1016/j.drugalcdep.2008.01.013  0.4
2008 Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C. Identification of pharmacogenetic markers in smoking cessation therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 712-9. PMID 18165968 DOI: 10.1002/ajmg.b.30669  0.52
2007 Wang Z, Faith M, Patterson F, Tang K, Kerrin K, Wileyto EP, Detre JA, Lerman C. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14035-40. PMID 18094242 DOI: 10.1523/JNEUROSCI.2966-07.2007  0.52
2007 Schnoll RA, Wileyto EP, Hornik R, Schiller J, Lerman C. Spiral computed tomography and lung cancer: science, the media, and public opinion. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5695-7. PMID 18089863 DOI: 10.1200/JCO.2007.13.5228  0.48
2007 Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: S583-98. PMID 18067034 DOI: 10.1080/14622200701691755  0.52
2007 David SP, Strong DR, Munafò MR, Brown RA, Lloyd-Richardson EE, Wileyto PE, Evins EA, Shields PG, Lerman C, Niaura R. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1251-7. PMID 18058343 DOI: 10.1080/14622200701705027  0.52
2007 Lerman CE, Schnoll RA, Munafò MR. Genetics and smoking cessation improving outcomes in smokers at risk. American Journal of Preventive Medicine. 33: S398-405. PMID 18021915 DOI: 10.1016/j.amepre.2007.09.006  0.48
2007 Ray R, Jepson C, Wileyto EP, Dahl JP, Patterson F, Rukstalis M, Pinto A, Berrettini W, Lerman C. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1237-41. PMID 17978999 DOI: 10.1080/14622200701648367  0.52
2007 Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. Journal of Women's Health (2002). 16: 1211-8. PMID 17937574 DOI: 10.1089/jwh.2006.0281  0.48
2007 Schnoll RA, Johnson TA, Lerman C. Genetics and smoking behavior. Current Psychiatry Reports. 9: 349-57. PMID 17915073 DOI: 10.1007/s11920-007-0045-3  0.52
2007 Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Archives of General Psychiatry. 64: 1078-86. PMID 17768273 DOI: 10.1001/archpsyc.64.9.1078  0.52
2007 Lerman C, LeSage MG, Perkins KA, O'Malley SS, Siegel SJ, Benowitz NL, Corrigall WA. Translational research in medication development for nicotine dependence. Nature Reviews. Drug Discovery. 6: 746-62. PMID 17690709 DOI: 10.1038/nrd2361  0.52
2007 Ray R, Schnoll RA, Lerman C. Pharmacogenetics and smoking cessation with nicotine replacement therapy. Cns Drugs. 21: 525-33. PMID 17579497  0.52
2006 Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clinical Pharmacology and Therapeutics. 79: 600-8. PMID 16765148 DOI: 10.1016/j.clpt.2006.02.006  0.52
2004 Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, Hawk L, Epstein LH. Effect of bupropion on depression symptoms in a smoking cessation clinical trial Psychology of Addictive Behaviors. 18: 362-366. PMID 15631608 DOI: 10.1037/0893-164X.18.4.362  0.52
2003 Lerman C, Wileyto EP, Audrain J, Pinto A, Kucharski S, Niaura R, Shields PG, Hawk LH, Krishnan S, Epstein LH. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial Health Psychology. 22: 541-548. PMID 14570538 DOI: 10.1037/0278-6133.22.5.541  0.52
2002 Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Pharmacogenetic investigation of smoking cessation treatment Pharmacogenetics. 12: 627-634. PMID 12439223 DOI: 10.1097/00008571-200211000-00007  0.52
2002 Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Mediating mechanisms for the impact of bupropion in smoking cessation treatment Drug and Alcohol Dependence. 67: 219-223. PMID 12095672 DOI: 10.1016/S0376-8716(02)00067-4  0.52
2001 Lerman C, Audrain J, Tercyak K, Hawk LW, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 3: 353-9. PMID 11694203 DOI: 10.1080/14622200110072156  0.52
Show low-probability matches.